Tower Research Capital (TRC)’s MyoKardia, Inc. Common Stock MYOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-11,507
| Closed | -$1.57M | – | 5612 |
|
|
2020
Q3 | $1.57M | Sell |
11,507
-1,286
| -10% | -$137K | 0.02% | 571 |
|
|
2020
Q2 | $1.24M | Buy |
12,793
+8,151
| +176% | +$680K | 0.05% | 401 |
|
|
2020
Q1 | $218K | Buy |
4,642
+3,900
| +526% | +$250K | 0.01% | 718 |
|
|
2019
Q4 | $54K | Buy |
+742
| New | +$45K | ﹤0.01% | 1297 |
|
|
2019
Q3 | – | Sell |
-314
| Closed | -$16K | – | 4762 |
|
|
2019
Q2 | $16K | Buy |
+314
| New | +$15.3K | ﹤0.01% | 2317 |
|
|
2019
Q1 | – | Sell |
-784
| Closed | -$39K | – | 4592 |
|
|
2018
Q4 | $39K | Buy |
+784
| New | +$43.2K | ﹤0.01% | 1461 |
|
|
2018
Q3 | – | Sell |
-3
| Closed | – | – | 4474 |
|
|
2018
Q2 | $0 | Sell |
3
-287
| -99% | -$13.9K | ﹤0.01% | 4289 |
|
|
2018
Q1 | $14K | Sell |
290
-1,223
| -81% | -$63.6K | ﹤0.01% | 2344 |
|
|
2017
Q4 | $64K | Buy |
1,513
+959
| +173% | +$37K | 0.01% | 1154 |
|
|
2017
Q3 | $24K | Buy |
554
+454
| +454% | +$14.5K | ﹤0.01% | 2631 |
|
|
2017
Q2 | $1K | Hold |
100
| – | – | ﹤0.01% | 2560 |
|
|
2017
Q1 | $1K | Buy |
+100
| New | +$1.28K | ﹤0.01% | 2908 |
|
|
2016
Q4 | – | Sell |
-3,360
| Closed | -$55K | – | 4659 |
|
|
2016
Q3 | $55K | Buy |
3,360
+1,822
| +118% | +$32.9K | 0.01% | 1100 |
|
|
2016
Q2 | $19K | Buy |
1,538
+1,346
| +701% | +$16.8K | ﹤0.01% | 2291 |
|
|
2016
Q1 | $2K | Sell |
192
-70
| -27% | -$637 | ﹤0.01% | 3509 |
|
|
2015
Q4 | $4K | Buy |
+262
| New | +$3.21K | ﹤0.01% | 3304 |
|
Tower Research Capital (TRC)'s MYOK Position: Q4 2020 in Review
Tower Research Capital (TRC) sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 11,507 shares — an estimated $1.57M sold.
Tower Research Capital (TRC) first reported a position in MYOK in Q4 2015 and held it in 16 quarters. The position peaked at $1.57M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.
- Tower Research Capital (TRC) reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
- Tower Research Capital (TRC) sold 11,507 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $1.57M.
- Tower Research Capital (TRC) first reported a position in MyoKardia, Inc. Common Stock in Q4 2015 and held it in 16 quarters.
- Tower Research Capital (TRC)'s MyoKardia, Inc. Common Stock position peaked at $1.57M in Q3 2020.
- 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.
Based on Tower Research Capital (TRC)'s 13F filing for Q4 2020, filed 16 Feb 2021.